Literature DB >> 1269981

Abnormal intestinal bile acid distribution in azotaemic man: a possible role in the pathogenesis of uraemic diarrhoea.

S J Gordon, L J Miller, L J Haeffner, M D Kinsey, O D Kowlessar.   

Abstract

Proximal intestinal bile acids have been studied in 14 ambulatory patients with varying degrees of azotaemia. When compared with normal subjects, the azotaemic patients showed a significant decrease in deoxycholic acid. Analysis of faecal bile acids of a patient with low intestinal deoxycholic acid also showed low deoxycholic acid with a preponderance of primary bile acids, and contrast with faecal bile acids of a normal subject and a patient with normal intestinal deoxycholic acid. It is suggested that impairment of deconjugation or 7alpha-dehydroxylation might be contributing to the low deoxycholic acid observed in azotaemic patients. Unusual bile acids: ursodeoxycholic acid, 3-hydroxy-7-keto-cholanic acid, and 3,12-dihydroxy-7-keto-cholanic acid were also noted in intestinal aspirates of azotaemic patients. The presence of these bile acids in conjunction with low deoxycholic acid correlates with the symptom of diarrhoea in azotaemic patients, and may contribute to the pathogenesis of diarrhoea in these patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1269981      PMCID: PMC1411049          DOI: 10.1136/gut.17.1.58

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  29 in total

1.  FAECAL EXCRETION PRODUCTS OF CHOLIC ACID IN MAN.

Authors:  A NORMAN
Journal:  Br J Nutr       Date:  1964       Impact factor: 3.718

2.  QUANTITATIVE ISOLATION AND GAS--LIQUID CHROMATOGRAPHIC ANALYSIS OF TOTAL FECAL BILE ACIDS.

Authors:  S M GRUNDY; E H AHRENS; T A MIETTINEN
Journal:  J Lipid Res       Date:  1965-07       Impact factor: 5.922

3.  The effect of bile acids on intestinal microflora.

Authors:  M H Floch; H J Binder; B Filburn; W Gershengoren
Journal:  Am J Clin Nutr       Date:  1972-12       Impact factor: 7.045

4.  Factors affecting bile acid metabolism in cholerrheic enteropathy.

Authors:  W D Mitchell; J M Findlay; R Macrae; M A Eastwood; R Anderson
Journal:  Digestion       Date:  1974       Impact factor: 3.216

5.  Different effects of free and conjugated bile acids and their keto derivatives on (Na + ,K + )-stimulated and Mg 2 +ATPase of rat intestinal mucosa.

Authors:  G W Hepner; A F Hofmann
Journal:  Biochim Biophys Acta       Date:  1973-01-02

6.  Bile-salts in small intestinal contents after ileal resection and in other malabsorption syndromes.

Authors:  G M McLeod; H S Wiggins
Journal:  Lancet       Date:  1968-04-27       Impact factor: 79.321

7.  Disappearance of deoxycholic acid after ileal resection.

Authors:  F Kern
Journal:  Gastroenterology       Date:  1973-01       Impact factor: 22.682

8.  Increased ratio of glycine-taurine conjugated bile acids in the early diagnosis of terminal ileopathy. Preliminary report.

Authors:  A Bruusgaard; E H Thaysen
Journal:  Acta Med Scand       Date:  1970-12

9.  Degradation of bile salts by human intestinal bacteria.

Authors:  V Aries; J S Crowther; B S Drasar; M J Hill
Journal:  Gut       Date:  1969-07       Impact factor: 23.059

10.  The metabolism of urea and ammonia in the healthy and uraemic colon.

Authors:  O Wrong
Journal:  Med J Aust       Date:  1967-08-12       Impact factor: 7.738

View more
  3 in total

Review 1.  Differential regulation of EGFR-MAPK signaling by deoxycholic acid (DCA) and ursodeoxycholic acid (UDCA) in colon cancer.

Authors:  Sara M Centuori; Jesse D Martinez
Journal:  Dig Dis Sci       Date:  2014-06-11       Impact factor: 3.199

2.  Deoxycholic acid mediates non-canonical EGFR-MAPK activation through the induction of calcium signaling in colon cancer cells.

Authors:  Sara M Centuori; Cecil J Gomes; Jesse Trujillo; Jamie Borg; Joshua Brownlee; Charles W Putnam; Jesse D Martinez
Journal:  Biochim Biophys Acta       Date:  2016-04-13

3.  Chronic renal failure-induced changes in serum and urine bile acid profiles.

Authors:  F Jimenez; M J Monte; M Y El-Mir; M J Pascual; J J G Marin
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.